N ear-infrared spectroscopy (NIRS) is used increasingly during cardiac surgery to monitor regional cerebral oxygen saturation (rSco 2 ) as an indicator of cerebral perfusion adequacy, particularly during cardiopulmonary bypass (CPB). 1,2 Unlike pulse oximetry, NIRS monitoring does not distinguish arterial from venous blood. Because approximately 70% to 75% of cerebral blood volume is venous blood, rSco 2 provides an indicator of O 2 supplyversus-demand balance. 3 Case reports and observational studies have linked episodes of rSco 2 desaturation during BACKGROUND: The purpose of this multicenter pilot study was to: (1) determine the frequency of regional cerebral oxygen saturation (rSco 2 ) desaturations during cardiac surgery involving cardiopulmonary bypass (CPB); (2) evaluate the accuracy of clinician-identified rSco 2 desaturations compared with those recorded continuously during surgery by the near-infrared spectroscopy (NIRS) monitor; and (3) assess the effectiveness of an intervention algorithm for reversing rSco 2 desaturations. METHODS: Two hundred thirty-five patients undergoing coronary artery bypass graft and/or valvular surgery were enrolled at 8 US centers in this prospective observational study. NIRS (Invos™ 5100C; Covidien) was used to monitor rSco 2 during surgery. The frequency and magnitude of rSco 2 decrements >20% from preanesthesia baseline were documented, and the efficacy of a standard treatment algorithm for correcting rSco 2 was determined. The data from the NIRS monitor were downloaded at the conclusion of surgery and sent to the coordinating center where the number of clinician-identified rSco 2 desaturation events was compared with the number detected by the NIRS monitor. RESULTS: The average rSco 2 obtained at baseline (mean ± SD, 61% ± 11%; 99% confidence interval, 57%-65%) and during CPB (62% ± 14%; 57%-67%) was not different. However, rSco 2 after separation from CPB (56% ± 11%; 53%-60%) was lower than measurements at baseline and during CPB (P < 0.001). During CPB, rSco 2 desaturations occurred in 61% (99% confidence interval, 50%-75%) of patients. The area under the curve for product of magnitude and duration of the rSco 2 was (mean ± SD, 145.2; 384.8% × min). Clinicians identified all patients with an rSco 2 desaturation but identified only 340 (89.5%) of the 380 total desaturation events. Of the 340 clinician-identified rSco 2 desaturation events, 115 resolved with usual clinical care before implementation of the treatment algorithm. For the remaining 225 events, the treatment algorithm resulted in resolution of the rSco 2 desaturation in all but 18 patients. CONCLUSIONS: This multicenter pilot study found that 50% to 75% of patients undergoing cardiac surgery experience one or more rSco 2 desaturations during CPB. Nearly 10% of desaturation events were not identified by clinicians, suggesting that appropriate alarming systems should be adopted to alert clinicians of such events. The intervention algorithm was effective in reversing clinically identified rSco 2 desaturations in the majority of events. (Anesth Analg 2016;122:1786-93) From the
coronary artery bypass graft (CABG) surgery with risk for stroke and postoperative cognitive dysfunction. 1, 2 These studies, although, have limitations that confound the ability to interpret whether decrements in rSco 2 during surgery are clearly linked with adverse neurologic outcomes. 1, 2 Low rSco 2 may merely serve as an epiphenomenon identifying patients with cerebral vascular disease or limited cardiopulmonary reserve who are at high risk of complications. 4 Importantly, limited data are available on the effectiveness of interventions aimed at correcting rSco 2 desaturations and whether such interventions lead to improved patient neurologic outcomes. [5] [6] [7] [8] [9] [10] Many clinicians, administrators, and health care payers may desire a higher level of evidence than what is currently available on the benefits of NIRS monitoring before it is adopted for routine use in patients undergoing cardiac surgery. Such evidence would ideally come from multicenter prospective studies that compare the effect of interventions to correct rSco 2 desaturations with the effect of current standard of care on the frequency of neurologic complications. As a first step to achieve this goal, in this pilot study, we assembled a group of investigators at 8 US institutions to: (1) determine the frequency of rSco 2 desaturations during cardiac surgery with CPB; (2) compare the accuracy of clinician-identified rSco 2 desaturations with that of continuous NIRS monitoring during surgery; and (3) assess the effectiveness of an intervention algorithm for reversing rSco 2 desaturations. We hypothesized that rSco 2 desaturations are frequent during CPB and that a multicenter network of investigators can successfully follow an intervention algorithm and accurately report their data to a central data-coordinating center. As a proof of concept construct, the intent of the study was not to link desaturations or their correction to specific outcomes. However, these data may be of value to clinicians for establishing reference ranges of rSco 2 and for evaluating potential interventions for treating rSco 2 desaturations.
METHODS
The procedures of this study were approved by The Johns Hopkins Medical Institutions Human Research Review Board. The procedures further met with the approval of the IRBs of 7 
Data Collection and Patient Monitoring
From November 8, 2013, to March 4, 2015, 239 patients were enrolled at the 8 study sites; this analysis focuses on 235 patients with nonmissing demographic and medical history data. Male and female patients were eligible for inclusion if they were >50 years old and undergoing primary or reoperative CABG and/or cardiac valve surgery. Enrolled patients at each research site were assigned a sequential 3-digit study number and a 4-character alpha code. Study data were collected on a paper case report form provided by the coordinating center (The Johns Hopkins University School of Medicine). The collected data included preoperative demographics and medical history. Medical conditions such as hypertension, prior stroke or transient ischemic attack, congestive heart failure, and other diseases were based on diagnosis by the patient's primary medical team.
The patients received institutionally standard anesthesia and surgery care, including direct arterial blood pressure monitoring. Before the induction of general anesthesia, the patients were connected to an NIRS monitor (Invos™ 5100C; Covidien, Boulder, CO). The forehead was cleansed with an alcohol swab, and 2 self-adhesive probes were attached according to manufacturer's guidelines. Baseline rSco 2 readings were obtained, while the patients were breathing room air. Nonpulsatile CPB flow was maintained between 2.0 and 2.4 L/min/m 2 . The patients were managed with α-stat pH management. There was no standardized algorithm for blood transfusion.
rSco 2 Data Collection and Intervention Algorithm
An episode of rSco 2 desaturation was defined as a >20% decline from baseline detected from either the right or the left sensor. During surgery, the time of any rSco 2 desaturation was recorded on the study data sheet. Management of these rSco 2 desaturations followed an algorithm as proposed by Murkin et al. 11 and Denault et al. 12 (Fig. 1 ). Clinicians and perfusionists were instructed on the study procedures and the treatment algorithm for rSco 2 desaturation. They then recorded each sequential intervention and the time when the rSco 2 desaturation was corrected. Subsequent rSco 2 desaturations were similarly treated and recorded when they occurred. At the conclusion of the surgery, rSco 2 data files from the NIRS monitor were downloaded to a USB driver.
Study demographic and other data were recorded onto the case report forms, which was then transferred to an Excel spreadsheet (Microsoft, Inc., Redmond, WA) format. Once completed, the electronic case report form was uploaded onto an Internet, study-specific, encrypted Web site supported by MedDium, Inc. (Bethesda, MD, https:// www.meddium.com/). The rSco 2 data from the NIRS monitor were also uploaded to the same Web site. Only deidentified data for a patient assigned a study number and alpha code were uploaded. The study data could be reviewed only by authorized personnel at the coordinating center.
Sample Size Calculation and Data Analysis
The primary outcome of this pilot study was the combined frequency of rSco 2 desaturations from all enrolling centers. The frequency of this event is not known and was the aim of this study. We sought to enroll 28 patients at each site or a total of 225 patients. We added an additional 14 patients to this sample size as a buffer in case any protocol was incomplete. This sample size was chosen to be similar to that reported by Murkin et al. 11 who observed rSco 2 desaturation in 56% of 200 patients. In that study, the interventions to correct the rSco 2 desaturations were effective in 80.4% of episodes. Thus, we expected 126 episodes of rSco 2 desaturation during surgery in this pilot study.
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Multicenter Study of Regional Cerebral Oxygen Desaturations Demographic, prior medical, and preoperative data are presented as mean ± SD or median (range) for continuous variables and frequencies for categorical variables and compared using 1-way analysis of variance, Kruskal-Wallis, or χ 2 tests across the study sites. Pairwise comparisons after significant overall test were performed considering multiple comparisons using the Tukey method. The overall proportion of desaturation events was estimated for the entire sample and for each site. Ninety-nine percent confidence intervals (CI) are reported for all estimates; they were calculated using generalized linear models with sitespecific robust variance estimates to account for potential nonindependence of observations within sites. rSco 2 at baseline, the start of CPB, and the end of CPB was summarized and compared using generalized linear model with time (start and end of CPB versus baseline) as the primary independent variable. The model was estimated using generalized estimating equations with exchangeable working correlation structure to account for within-patient correlation of rSco 2 levels over time. We evaluated the accuracy of clinician-identified rSco 2 desaturations by comparing the number and the frequency of investigator-reported rSco 2 saturations to the number recorded continuously by the NIRS monitor during surgery. The severity of rSco 2 desaturations was determined as the area under the curve of magnitude and duration of rSco 2 desaturations. The latter was determined off-line at the coordinating center from the uploaded rSco 2 data. The number and specific type of each sequential intervention for rSco 2 desaturation were determined. Compliance with the intervention algorithm for rSco 2 desaturation was defined as a clinician's successful correction of each rSco 2 desaturation episode identified by retrospective review of the patient's NIRS monitor data file.
RESULTS
Data were successfully collected from 235 patients. The medical and operative characteristics of the enrolled patients are shown in Table 1 and the Supplemental Table  1 (Supplemental Digital Content, http://links.lww.com/ AA/B408). There were differences among the enrolling sites in some characteristics, including patient age, race, history of congestive heart failure, type of surgical procedure, and duration of CPB and aortic cross-clamping.
Baseline rSco 2 and results obtained during and after separation from CPB are shown in Figure 2 . Average baseline rSco 2 for the left, right, and the average of the left and right frontal lobes, respectively, were (mean ± SD; 99% CI) 61% ± 11% (57%-65%), 61% ± 12% (58%-65%), and 61% ± 11% (57%-67%). During CPB, the average rSco 2 measurements were 62% ± 14% (57%-66%), 62% ± 15% (57%-67%), and 62% ± 14% (57%-67%) for the left, right, and the average of the left and right sides, respectively. After CPB, these results were 56% ± 11% (53%-60%), 56% ± 12% (52%-60%), and 56% ± 11% (53%-60%). The average rSco 2 during CPB was no different than baseline (P = 0.338), but rSco 2 after separation from CPB was lower than that at baseline and that recorded during CPB after adjustment for site (P < 0.001). rSco 2 values differed among enrolling sites. The average rSco 2 was lower at Duke University Hospital than that at the Mayo Clinic before (P < 0.001), during (P = 0.001), and after CPB (P = 0.004). The average rSco 2 also was lower at Duke University Hospital than that at The Johns Hopkins Hospital before CPB (P = 0.001). Thirty-one (15%; 99% CI, 5%-41%) patients had baseline left-sided rSco 2 <50%, and 34 (15%; 99% CI, 6%-37%) had baseline right-sided rSco 2 <50%, while breathing room air.
The frequency of rSco 2 desaturations during CPB for all patients, as well as that observed at each enrolling site, is shown in Table 2 . One or more rSco 2 desaturations occurred in 61% (99% CI, 50%-75%) of patients during CPB. A total of 380 desaturation events were detected from data downloaded from the NIRS monitor at the conclusion of surgery. The frequency of desaturation varied among enrolling sites (P = 0.023). After adjusting for multiple comparisons, we identified a difference in the frequency of rSco 2 desaturation between the Mayo Clinic and Duke (P = 0.004), Emory University and the Mayo Clinic (P = 0.027), and the Mayo Clinic and the University of Virginia (P = 0.032). Clinicians detected all patients with at least 1 rSco 2 desaturation during CPB, but they identified 340 (89.5%) of the 380 desaturation events.
The effectiveness of each intervention for reversing rSco 2 desaturation is shown in Table 3 . There was spontaneous resolution of the desaturation in 115 events. For the remaining 225 events, treating hypotension was the most effective strategy for correcting rSco 2 desaturation. Desaturations remained unresolved during CPB in 18 (5%; 99% CI, 3%-10%) of the 340 events. Of the patients with resolved desaturations, 1 intervention was needed in 70 events, 2 interventions in 57 events, 3 interventions in 28, and >3 interventions were needed in 65 events.
DISCUSSION
In this study, we observed that the average rSco 2 during CPB was no different from that at baseline. However, average rSco 2 decreased after separation from CPB compared with values measured at baseline and during CPB. Desaturation in rSco 2 occurred in 61% (99% CI, 50%-75%) of patients. NIRS monitoring recorded 380 desaturation events, of which clinicians identified 340 (89.5%). In all but 5% (99% CI, 3%-10%) of patients, there was either resolution of rSco 2 desaturations with usual clinical care or they were corrected by the intervention algorithm. www.anesthesia-analgesia.org
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Multicenter Study of Regional Cerebral Oxygen Desaturations Many clinicians have embraced rSco 2 monitoring as a means for judging the adequacy of cerebral perfusion during CPB in an effort to reduce the risk for adverse neurologic events. Currently, only a low level of evidence supports the use of rSco 2 monitoring for this purpose. In a previously published systematic review, our group identified 43 articles involving 6399 patients that evaluated the relationship between rSco 2 monitoring and adverse neurologic outcomes after cardiac surgery. 1 The identified citations included 13 case reports and 27 observational studies. These reports provided anecdotal evidence that rSco 2 desaturations can be indicative of rare CPB cannula malposition, allowing for timely surgical adjustments. Although the data were not consistent, some observational studies linked rSco 2 desaturations during CPB and postoperative cognitive dysfunction or stroke. Interpretation of these studies, however, is confounded by small sample sizes, the use of a limited psychometric testing battery in many of the studies, the lack of patient testing after hospital discharge, use of historical controls, the failure to risk adjust in the data analysis, and the use of monitors from multiple manufacturers.
In our systematic review, we identified 2 studies in which patients were prospectively randomized to an intervention to treat rSco 2 desaturations during CPB. 11, 13 Poor adherence to the intervention protocol in the study by Slater et al., 13 however, limits interpretation of those results. Murkin et al. 11 randomly assigned 200 patients undergoing CABG surgery to 2 groups. In one, patients with rSco 2 desaturations >30% below baseline were treated with a stepped intervention algorithm. These patients were compared with a control group for whom rSco 2 data were collected but not displayed to clinicians. In that study, the patients in the control group had longer rSco 2 desaturations (P = 0.014), a higher frequency of a composite organ complication end point (death, ventilation >48 hours, stroke, myocardial infarction, return for re-exploration [P = 0.048], and longer hospitalization in the intensive care unit [P = 0.029]) than did patients in the intervention arm. Episodes of rSco 2 desaturation were observed in 56 of 100 patients in the intervention group, and the success rate of the rSco 2 desaturation intervention was 80.4%. The study by Murkin et al. did not have adequate power to detect a difference in neurologic complications. Moreover, the sample size calculations assumed a complication rate in the control arm of 40%, whereas the observed rate was 30%.
A higher level of evidence than is currently available seems desirable to justify routine rSco 2 monitoring for the approximately 600,000 patients who undergo CABG and/or valvular surgery annually in the United States. 14 Its use may be justified given the devastating consequences of stroke and cognitive complications after cardiac surgery, including high costs of care for affected patients. For example, postoperative stroke alone adds an average of 15 days to the length of hospitalization after cardiac surgery, increases hospital costs by >$35,000, and increases the likelihood of discharge to an extended care facility after surgery. [15] [16] [17] In this study, we demonstrated the frequency of rSco 2 desaturations, the feasibility of multicenter collection of rSco 2 monitoring data, and the application of an intervention algorithm for desaturations. These results would be useful in the design of a comparative effectiveness trial that evaluates the costbenefit relationship of rSco 2 monitoring in patients undergoing cardiac surgery.
There is no universal definition of rSco 2 desaturation. Widely reported definitions are based largely on older data obtained from patients undergoing carotid endarterectomy surgery. In those studies, decrements in rSco 2 between 5% and 20% from baseline or values <50% ipsilateral to carotid Mean (SD). rSco 2 = Regional cerebral oxygen saturation There was resolution of 115 desaturation events with usual clinical care and not the treatment algorithm. The data are listed as the number of desaturation of events that were not spontaneously corrected with percentage based on the event effectiveness versus all events that responded to any intervention (n = 225). In 18 (8%) patients, the rSco 2 was unresolved despite interventions. CPB = cardiopulmonary bypass; RBC = red blood cell.
artery cross-clamping were associated with reductions in transcranial Doppler-measured cerebral blood flow velocity, electroencephalogram slowing, alterations in somatosensory-evoked potentials, or mental status changes when surgery was performed under regional anesthesia. 1 In this study, we defined rSco 2 desaturation as a >20% decline from baseline but did not use a threshold value such as decrements <50%. Many patients have baseline rSco 2 <50% that may result from factors other than acute reduction in cerebral oxygenation, such as low cardiac output, pulmonary disease, cerebral vascular disease, and anemia. Indeed, in this study, baseline rSco 2 <50% was observed on the left side in 13% of patients and on the right side in 14% of patients, before induction of anesthesia. We observed a baseline averaged rSco 2 of 61% ± 11% (99% CI, 57%-65%). In a singlecenter study of 250 CABG surgery patients, the reported ranges of rSco 2 before cardiac surgery varied between 47% and 83%. 5 In a larger prospective study of 1178 patients, preoperative room air rSco 2 ranged from 57% to 67% for survivors but 47% to 62% for nonsurvivors after CABG surgery. 4 We did observe differences in the baseline rSco 2 value among enrolling sites that might be explained by differences in patient age, race, or preoperative medical conditions among the centers. Differences in the frequency of desaturation and greater responsiveness to interventions in our study compared with those reported by Murkin et al. 11 might be explained, in part, by the different definitions of desaturation (>20% from baseline versus >30% decrement). In our study, clinicians were not blinded to rSco 2 data. We observed that there was resolution of the clinicianidentified rSco 2 desaturation in 115 (34%) of 340 events with usual clinical care. We did not include a threshold duration in our definition of desaturation. Thus, many of these events with resolution before implementation of the treatment algorithm were likely of short duration. Clinicians might have further intervened with corrective maneuvers (e.g., increasing CPB flow after transient reduction) before institution of the algorithm. Furthermore, our intent was to simulate a usual clinical environment of NIRS monitoring to enhance the external validity of our findings. Thus, we did not specify a protocol for setting the alarms on the NIRS monitor. Regardless, the treatment of hypotension was the most effective intervention at reversing rSco 2 desaturations. In the randomized study by Murkin et al., raising blood pressure was effective in 62% of cases, and increasing CPB flow was the second most effective intervention. 18 We did not record which medications were used to raise blood pressure. Drugs with vasoconstrictive properties potentially could influence rSco 2 readings indirectly as a result of their effects on the scalp circulation. This potential effect is related to the imprecise subtraction algorithms used by NIRS monitors, whereby light absorption from superficial tissue is subtracted from absorption in deeper tissue to yield frontal lobe rSco 2 . 1, 19, 20 Hypothetically, vasoconstriction of scalp blood vessels could reduce rSco 2 readings regardless of any benefit of higher blood pressure on cerebral blood flow. However, in this investigation, we observed correction of rSco 2 desaturation with raised blood pressure. Regardless of these theoretical concerns, investigations during carotid endarterectomy surgery found that changes in rSco 2 were 87.5% sensitive and 100% specific for identifying changes in transcranial Doppler blood flow velocity during selective clamping of the internal carotid artery. At the same time, rSco 2 monitoring had 0% sensitivity and specificity for identifying laser Doppler blood flow velocity of the scalp during selective clamping of the external carotid artery. 21 We observed that 57% (i.e., 193 of 340) of cliniciandetected rSco 2 desaturations were unilateral. This observation may explain why 3% of desaturation events responded to a repositioning of the head to the midline. Presumably, head position away from the midline might impede cerebral venous return and reduce cerebral perfusion pressure. Malposition of CPB venous or arterial cannulae might also explain some cases of unilateral rSco 2 desaturation. Repositioning of CPB cannulae was effective in 8% of cases. The most effective interventions for rSco 2 desaturation collectively were those aimed at improving cerebral oxygen delivery included increasing the Fio 2 % of gas delivery, avoiding the cerebral vasoconstrictive effects of hypocapnia by decreasing gas flow to the membrane oxygenator (i.e., decreasing "sweep speed"), ensuring appropriate CPB flow, and increasing oxygen-carrying capacity with red blood cell transfusion. These efforts were effective in 55% of desaturation events that were not spontaneously corrected with usual clinical care.
In this study, we did not relate rSco 2 desaturations or their treatment to patient outcomes. The small sample size and limited funding available did not permit our team to collect such outcomes. Regardless, this study was meant as a pilot to establish feasibility for performing such a study. Finally, our definition of desaturation did not include the duration that rSco 2 was >20% below baseline. Although short and long desaturations were considered equally, we did quantify severity by calculating area under the curve of events.
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